Pfizer Inc Cdr Stock Price Prediction
| PFE Stock | 11.68 0.08 0.69% |
Oversold Vs Overbought
34
Oversold | Overbought |
Quarterly Earnings Growth (0.98) | Quarterly Revenue Growth 0.312 |
Using Pfizer hype-based prediction, you can estimate the value of Pfizer Inc CDR from the perspective of Pfizer response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pfizer to buy its stock at a price that has no basis in reality. In that case, they are not buying Pfizer because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pfizer after-hype prediction price | CAD 11.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pfizer |
Pfizer After-Hype Price Prediction Density Analysis
As far as predicting the price of Pfizer at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pfizer or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pfizer, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pfizer Estimiated After-Hype Price Volatility
In the context of predicting Pfizer's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pfizer's historical news coverage. Pfizer's after-hype downside and upside margins for the prediction period are 10.33 and 13.01, respectively. We have considered Pfizer's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pfizer is not too volatile at this time. Analysis and calculation of next after-hype price of Pfizer Inc CDR is based on 3 months time horizon.
Pfizer Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pfizer, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 1.35 | 0.01 | 0.01 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
11.68 | 11.67 | 0.09 |
|
Pfizer Hype Timeline
Pfizer Inc CDR is at this time traded for 11.68on NEO Exchange of Canada. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. Pfizer is estimated to decline in value after the next headline, with the price expected to drop to 11.67. The average volatility of media hype impact on the company price is over 100%. The price decline on the next news is expected to be -0.09%, whereas the daily expected return is at this time at -0.2%. The volatility of related hype on Pfizer is about 2250.0%, with the expected price after the next announcement by competition of 11.67. The company has price-to-book ratio of 1.5. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pfizer Inc CDR has Price/Earnings To Growth (PEG) ratio of 0.17. The entity last dividend was issued on the 8th of November 2024. Assuming the 90 days trading horizon the next estimated press release will be very soon. Check out Pfizer Basic Forecasting Models to cross-verify your projections.Pfizer Related Hype Analysis
Having access to credible news sources related to Pfizer's direct competition is more important than ever and may enhance your ability to predict Pfizer's future price movements. Getting to know how Pfizer's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pfizer may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BDT | Bird Construction | (0.33) | 4 per month | 2.11 | 0.08 | 3.79 | (2.89) | 20.64 | |
| QIPT | Quipt Home Medical | 0.05 | 2 per month | 0.00 | (0.09) | 3.73 | (4.71) | 14.13 | |
| TGS | TGS Esports | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DCM | Data Communications Management | (0.07) | 2 per month | 0.00 | (0.17) | 3.15 | (3.39) | 35.85 | |
| PTFY | Plantify Foods | 0.00 | 2 per month | 0.00 | (0.01) | 0.00 | 0.00 | 6.00 | |
| NLH | Nova Leap Health | (0.01) | 2 per month | 3.11 | (0.02) | 7.41 | (7.41) | 18.37 |
Pfizer Additional Predictive Modules
Most predictive techniques to examine Pfizer price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pfizer using various technical indicators. When you analyze Pfizer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pfizer Predictive Indicators
The successful prediction of Pfizer stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pfizer Inc CDR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pfizer based on analysis of Pfizer hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pfizer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pfizer's related companies.
Story Coverage note for Pfizer
The number of cover stories for Pfizer depends on current market conditions and Pfizer's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pfizer is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pfizer's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Pfizer Short Properties
Pfizer's future price predictability will typically decrease when Pfizer's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pfizer Inc CDR often depends not only on the future outlook of the potential Pfizer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pfizer's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.6 B |
Other Information on Investing in Pfizer Stock
Pfizer financial ratios help investors to determine whether Pfizer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pfizer with respect to the benefits of owning Pfizer security.